Subscribe to RSS
DOI: 10.1055/a-2755-6966
Increased Tumor Size on Angio-CT during Yttrium-90 Compared to Preprocedural Cross-sectional Imaging Studies
Authors
Funding None.
Abstract
Purpose
To evaluate changes in liver tumor size between preprocedural cross-sectional imaging and intraprocedural angio-CT among patients undergoing transarterial radioembolization.
Methods
A total of 128 patients with 153 tumors (58 female, 45.3%; mean age: 64.9 ± 9.86 years) were retrospectively reviewed from January 1, 2021, to December 31, 2023. Baseline patient characteristics and tumor sizes were collected. Radiologic response and progression-free survival (PFS) were analyzed. Statistical analysis was performed using STATA 18.0 (StataCorp, College Station, Texas).
Results
The average tumor size increased on angio-CT compared to preprocedural imaging (4.97 ± 2.98 cm vs. 4.55 ± 2.97 cm, p < 0.0001) over a time interval of 37.29 ± 27.70 days, with an average change of 0.42 ± 0.62 cm. Tumors with a delay of more than 1 month between preprocedural imaging and angio-CT showed a greater increase in size (0.59 ± 0.66 cm vs. 0.21 ± 0.49 cm, p = 0.0001). Tumors with a 30% or greater interval size increase were associated with worse PFS (p = 0.0049).
Conclusion
Intraprocedural angio-CT can detect tumor growth during radioembolization mapping or administration. Tumor growth is most significant when there is a longer delay between preprocedural imaging and the procedure, and this growth correlates with PFS. Intraprocedural angio-CT provides critical prognostic information that can potentially influence treatment algorithms and should be regarded as a valuable component of interventional oncology procedures.
Publication History
Received: 04 June 2025
Accepted: 25 November 2025
Article published online:
07 January 2026
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Matsumoto MM, Nijhawan K, Leef JA, Dorsey C, Ahmed O. Hybrid CT-angiography to facilitate lower extremity sharp venous recanalization: a novel approach to a common procedure. CVIR Endovasc 2020; 3 (01) 51
- 2 Puijk RS, Nieuwenhuizen S, van den Bemd BAT. et al. Transcatheter CT hepatic arteriography compared with conventional CT fluoroscopy guidance in percutaneous thermal ablation to treat colorectal liver metastases: a single-center comparative analysis of 2 historical cohorts. J Vasc Interv Radiol 2020; 31 (11) 1772-1783
- 3 Feinberg N, Funaki B, Hieromnimon M. et al. Improved utilization following conversion of a fluoroscopy suite to hybrid CT/angiography system. J Vasc Interv Radiol 2020; 31 (11) 1857-1863
- 4 Kwak DH, Ahmed O, Habib H, Nijhawan K, Kumari D, Patel M. Hybrid CT-angiography (angio-CT) for combined CT and fluoroscopic procedures in interventional radiology enhances utilization. Abdom Radiol (NY) 2022; 47 (08) 2704-2711
- 5 Fergus J, Nijhawan K, Feinberg N. et al. Implementation of a hybrid angiography-CT system: increased short-term revenue at an academic radiology department. Abdom Radiol (NY) 2021; 46 (11) 5428-5433
- 6 Kwak DH, Lionberg A, Patel M. et al. Quantitative differences in volumetric calculations for radiation dosimetry in segmental Y90 treatment planning using hybrid angiography-CT compared with anatomic segmentation. Br J Radiol 2024; 97 (1154) 353-362
- 7 Yu Q, Knight G, Karani K. et al. Real-time arteriography-directed percutaneous microwave ablation for small or poorly characterized hepatic lesions using hybrid angio-CT. Abdom Radiol (NY) 2022; 47 (04) 1457-1463
- 8 Lionberg A, Nijhawan K, Navuluri R. et al. Hybrid angiography-CT for transarterial radioembolization: a pictorial essay. Abdom Radiol (NY) 2021; 46 (06) 2850-2854
- 9 Taiji R, Lin EY, Lin Y-M. et al. Combined angio-CT systems: a roadmap tool for precision therapy in interventional oncology. Radiol Imaging Cancer 2021; 3 (05) e210039
- 10 Tanaka T, Arai Y, Inaba Y. et al. Current role of hybrid CT/angiography system compared with C-arm cone beam CT for interventional oncology. Br J Radiol 2014; 87 (1041) 20140126
- 11 Salem R, Gordon AC, Mouli S. et al. Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology 2016; 151 (06) 1155-1163.e2
- 12 Yu Q, Neale M, Ungchusri E. et al. Tumor size and watershed area correlate with incomplete treatment and tumor progression after selective radioembolization for hepatocellular carcinoma. J Vasc Interv Radiol 2024; 35 (05) 712-721.e3
- 13 Dijkstra M, van der Lei S, Puijk RS. et al. Efficacy of thermal ablation for small-size (0–3 cm) versus intermediate-size (3–5 cm) colorectal liver metastases: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE). Cancers (Basel) 2023; 15 (17) 4346
